Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Early Response to Tegoprazan in Symptomatic GERD Patients: An Exploratory Clinical Study

NCT07826455 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT07826455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Early Response to Tegoprazan in Symptomatic GERD Patients: An Exploratory Clinical Study
Lead sponsor
HK inno.N Corporation
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
July 31, 2028
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gerd (gastroesophageal reflux disease)